1. Chemoresistance in Pancreatic Cancer
   null Zeng et al, 2019, International Journal of Molecular Sciences CrossRef
2. RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy
   Zhenxing Yang et al, 2019, BMC Urology CrossRef
3. Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
   Aditi Jain et al, 2021, World Journal of Gastroenterology CrossRef
4. Effect of ribonucleotide reductase M1 expression on overall survival in patients with pancreatic cancer receiving gemcitabine chemotherapy: A literature‐based meta‐analysis
   Q. L. Han et al, 2018, Journal of Clinical Pharmacy and Therapeutics CrossRef
5. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells
   Haibo Yu et al, 2017, Biomedicine & Pharmacotherapy CrossRef